amylyx pharmaceuticals inc biopharmaceutical company headquartered cambridge massachusetts amylyx best known experimental therapy amyotrophic lateral sclerosis approved medical use canada albrioza june united states relyvrio september amylyx pharmaceuticals founded joshua cohen justin klee two undergraduate students brown two proposed taurursodiol sodium phenylbutyrate together might prevent dysfunction mitochondria endoplasmic reticulum safeguarding klee cohen advised rudolph e tanzi ultimately served founding chair amylyxs scientific advisory board klee cohen able achieve strong results pre clinical research tanzi connected two colleagues massachusetts general hospital culminated clinical company granted million als association funds raised ice bucket amylyx went public january companys shares began trading nasdaq january symbol amlx httpsenwikipediaorgwikiamylyxpharmaceuticals